AgResearch to use SpectralWorks Software for Metabolomics Research
News Nov 04, 2009
Based at the Grasslands Research Centre in Palmerston North, their Metabolomics Scientists will use the data mining capabilities of AnalyzerPro® for both GC-MS and LC-MS research projects for the benefit of the agricultural sector within New Zealand. Scott Campbell, Director of SpectralWorks, says “We are very pleased to be associated with AgResearch with their vision to be the world’s foremost pastoral sector research and development organisation.”
AgResearch is an independent, Crown-owned research and development company focused on creating value in New Zealand’s pastoral and biotechnology sectors. Richard Curtis, Commercial Team Leader of the Applied Biotechnology Group said “The agreement with SpectralWorks is a significant step forward in our ability to develop systems to provide metabolomic analyses and services to the agriculture and biotechnology sectors in New Zealand and internationally. It provides options to use and develop innovative tools alongside our world-class metabolomics science team and we look forward to working with SpectralWorks to further develop this capability.”
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.